Efficient delivery of siRNA using dendritic poly(l-lysine) for loss-of-function analysis

Journal of Controlled Release

Volumn 126, Issue 1, 2008, Pages 59-66

  Inoue, Yusuke ^a   Kurihara, Ryosuke ^a   Tsuchida, Akiko ^b   Hasegawa, Mino ^b   Nagashima, Takeyuki ^b   Mori, Takeshi ^a   Niidome, Takuro ^a   Katayama, Yoshiki ^a,c   Okitsu, Osamu ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Dendrimer; Gluconeogenesis; Metformin; Organic cation transporter; RNAi

Indexed keywords

AMPHIPHILES; CELLS; CYTOTOXICITY; DENDRIMERS; GENE EXPRESSION; PEPTIDES;

GLUCONEOGENESIS; METFORMIN; ORGANIC CATION TRANSPORTERS;

RNA;

METFORMIN; ORGANIC CATION TRANSPORTER 1; POLYLYSINE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE TARGETING; GLUCONEOGENESIS; HEPATOMA CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT;

ANIMALS; CATECHOLAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DENDRIMERS; DRUG CARRIERS; GLUCONEOGENESIS; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE (NADP+); METFORMIN; POLYLYSINE; PROTEIN-SERINE-THREONINE KINASES; RATS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 38549099191     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.10.022     Document Type: Article

References (38)

1. Novina C.D., and Sharp P.A. The RNAi revolution. Nature 430 (2004) 161-164
2. Leung R.K.M., and Whittaker P.A. RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol. Ther. 107 2 (2005) 222-239
3. Aza-Blanc P., Cooper C.L., Wagner K., Batalov S., Deveraux Q.L., and Cooke M.P. Identification of modulators of TRAIL-Induced apoptosis via RNAi-based phenotypic screening. Mol. Cell 12 (2003) 627-637
4. Paddison P.J., Silva1 J.M., Conklin D.S., Schlabach M., Li M., Aruleba1 S., Balija1 V., O'Shaughnessy A., Gnoj L., Scobie K., Chang K., Westbrook T., Cleary M., Sachidanandam R., McCombie1 W.R., Elledge S.J., and Hannon G.J. A resource for large-scale RNA-interference-based screens in mammals. Nature 428 (2004) 427-431
5. Berns K., Hijmans E.M., Mullenders J., Brummelkamp T.R., Velds A., Heimerikx M., Kerkhoven R.M., Madiredjo M., Nijkamp W., Weigelt B., Agami R., Ge W., Cavet G., Linsley P.S., Beijersbergen R.L., and Bernards R. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428 (2004) 431-437
6. Westbrook T.F., Martin E.S., Schlabach M.R., Leng Y., Liang A.C., Feng B., Zhao J.J., Roberts T.M., Mandel G., Hannon G.J., DePinho R.A., Chin L., and Elledge1 S.J. A genetic screen for candidate tumor suppressors identifies REST. Cell 121 (2005) 837-848
7. Niidome T., and Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther. 9 (2002) 1647-1652
8. Kukowska-Latallo J.F., Bielinska A.U., Johnson J., Spindler R., Tomalia D.A., and Baker Jr. J.R. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc. Natl. Acad. Sci. U. S. A. 93 10 (1996) 4897-4902
9. Zhou J., Wu J., Hafdi N., Behr J.P., Erbacher P., and Peng L. PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chem. Commun. 22 (2006) 2362-2364
10. Tsutsumi T., Hirayama F., Uekama K., and Arima H. Evaluation of polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA). J. Control. Release 119 (2007) 349-359
11. Ohsaki M., Okuda T., Wada A., Hirayama T., Niidome T., and Aoyagi H. In vitro gene transfection using dendritic poly(l-lysine). Bioconjugate Chem. 13 (2002) 510-517
12. Yamagata M., Kawano T., Shiba K., Mori T., Katayama Y., and Niidome T. Structural advantage of dendritic poly(l-lysine) for gene delivery into cells. Bioorg. Med. Chem. 15 (2007) 526-532
13. Kawano T., Okuda T., Aoyagi H., and Niidome T. Long circulation of intravenously administered plasmid DNA delivered with dendritic poly(l-lysine) in the blood flow. J. Control. Release 99 (2004) 329-337
14. Okuda T., Kawakami S., Maeie T., Niidome T., Yamashita F., and Hashida M. Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration. J. Control. Release 114 (2006) 69--77
15. Okuda T., Kawakami S., Akimoto N., Niidome T., Yamashita F., and Hashida M. PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice. J. Control. Release 116 (2006) 330--336
16. Nordlie R.C., Foster J.D., and Lange A.J. Regulation of glucose production by the liver. Annu. Rev. Nutr. 19 (1999) 379-406
17. Radziuk J., and Pye S. Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis. Diabetes Metab. Res. Rev. 17 (2001) 250-272
18. Bailey C.J., and Turner R.C. Metformin. N. Engl. J. Med. 334 (1996) 574-579
19. Hundal R.S., Krssak M., Dufour S., Laurent D., Lebon V., Chandramouli V., Inzucchi S.E., Schumann W.C., Petersen K.F., Landau B.R., and Shulman G.I. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49 (2000) 2063-2069
20. Yuan L., Ziegler R., and Hamann A. Inhibition of phosphoenolpyruvate carboxykinase gene expression by metformin in cultured hepatocytes. Chin. Med. J. 115 12 (2002) 1843-1848
21. Morioka K., Nakatani K., Matsumoto K., Urakawa H., Kitagawa N., Katsuki A., Hori Y., Gabazza E.C., Yano Y., Nishioka J., Nobori T., Sumida Y., and Adachi Y. Metformin-induced suppression of glucose-6-phosphatase expression is independent of insulin signaling in rat hepatoma cells. Int. J. Mol. Med. 15 3 (2005) 449-452
22. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., and Moller D.E. Role of AMPK-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 8 (2001) 1167-1174
23. Zang M., Zuccollo A., Hou X., Nagata D., Walsh K., Herscovitz H., Brecher P., Ruderman N.B., and Cohen R.A. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J. Biol. Chem. 279 46 (2004) 47898-47905
24. Hawley S.A., Boudeau J., Reid J.L., Mustard K.J., Udd L., Mäkelä T.P., Alessi D.R., and Hardie D.G. Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2 28 (2003)
25. Shaw R.J., Kosmatka M., Bardeesy N., Hurley R.L., Witters L.A., DePinho R.A., and Cantley L.C. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. 101 10 (2004) 3329-3335
26. Woods A., Johnstone S.R., Dickerson K., Leiper F.C., Fryer L.G.D., Neumann D., Schlattner U., Wallimann T., Carlson M., and Carling1 D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13 (2003) 2004-2008
27. Shaw R.J., Lamia K.A., Vasquez D., Koo S.H., Bardeesy N., DePinho R.A., Montminy M., and Cantley L.C. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310 (2005) 1642-1646
28. Shitara Y., Toshiharu H., and Sugiyama Y. Transporters as a determinant of drug clearance and tissue distribution. Eur. J. Pharm. Sci. 27 (2006) 425-446
29. Koepsell H. Polyspecific organic cation transporters: their functions and interactions with drugs. Trends Pharmacol. Sci. 25 7 (2004) 375-381
30. Wang D.S., Kusuhara H., Kato Y., Jonker J.W., Schinkel A.H., and Sugiyama Y. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. Mol. Pharmacol. 63 4 (2003) 844-848
31. Gründemann D., Gorboulev V., Gambaryan S., Veyhl M., and Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372 (1994) 549-552
32. Okuda M., Saito H., Urakami Y., Takano M., and Inui K. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem. Biophys. Res. Commun. 224 (1996) 500-507
33. Wang D.S., Jonker J.W., Kato Y., Kusuhara H., Schinkel A.H., and Sugiyama Y. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. J. Pharmacol. Exp. Ther. 302 (2002) 510-515
34. Owen M.R., Doran E., and Halestrap A.P. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348 (2000) 607-614
35. Hofmann C., Marsh J.W., Miller B., and Steiner D.F. Cultured hepatoma cells as a model system for studying insulin processing and biologic responsiveness. Diabetes 29 11 (1980) 865-874
36. Summerton J.E. Endo-Porter: a novel reagent for safe, effective delivery of substances into cells. Ann. N. Y. Acad. Sci. 1058 (2005) 62-75
37. Quinn P.G., and Yeagley D. Insulin regulation of PEPCK gene expression: a model for rapid and reversible modulation. Curr. Drug Targets Immune Endocr. Metabol. Disord. 5 (2005) 423-437
38. Shu Y., Sheardown S.A., Brown C., Owen R.P., Zhang S., Castro R.A., Ianculescu A.G., Yue L., Lo J.C., Burchard E.G., Brett C.M., and Giacomini K.M. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J. Clin. Invest. 117 5 (2007) 1422-1431